We have demonstrated through in vitro experiments that IL-6 intervention in HUVECs can cause changes in the expression levels of endothelial dysfunction markers ICAM-1 and ZO-1 ——an increase in ICAM-1 expression and a decrease in ZO-1 expression. Here, TJP1 is linked to endothelial dysfunction.